Free Republic
Browse · Search
News/Activism
Topics · Post Article

Skip to comments.

U.S. panel sees brain cancer benefit with Roche drug (Fast Track for Kennedy Drug)
Reuters ^ | March 31, 2009 | Susan Heavey

Posted on 04/01/2009 3:57:54 AM PDT by Zakeet

Early data for Roche Holding AG's drug Avastin shows enough promise in treating patients with a certain brain cancer to be considered for quick approval, a U.S. advisory panel said on Tuesday.

The drugmaker is seeking accelerated approval to market the drug for patients diagnosed with a recurrence of the particularly deadly disease after trying other therapies first. The drug, made by its recently acquired Genentech unit, is already used to treat lung, colon and breast cancers.

Data from two early studies showed enough of a response in patients whose disease did not advance and some whose tumors decreased in size to warrant faster approval before the company finishes a larger trial to confirm the benefit, the panel said in a 10-0 vote.

"I think these results are dramatic," said panel member Jay Loeffler, head of radiation oncology at Massachusetts General Hospital in Boston.

Many panelists also said they were optimistic that the company's larger, long-term trial would confirm Avastin's benefits for patients with glioblastoma multiforme, an especially fatal tumor.

Company officials said the trial, which would target newly diagnosed patients, would begin enrolling patients soon and would have full results in 2014. Meanwhile, earlier data looked promising enough to help patients now, especially with few other treatments available.

"We're confident that we have met the criteria for accelerated approval," said David Schenkein, senior vice president for cancer products at Genentech, which saw U.S. net sales of $2.7 billion from Avastin in 2008.

Glioblastoma has seen renewed public attention since Senator Edward Kennedy was diagnosed with the malignant tumor last year. It is one of the deadliest types of cancer, with patients surviving six to 12 months after diagnosis on average, or six months without treatment.

(Excerpt) Read more at reuters.com ...


TOPICS: Business/Economy; Government; News/Current Events
KEYWORDS: avastin; cancer; fasttrack; roche

Fast track an amazing coincidence, perhaps?

1 posted on 04/01/2009 3:57:55 AM PDT by Zakeet
[ Post Reply | Private Reply | View Replies]

To: Zakeet

I’m sure all of you peasants will have the same access to these treatments as does any liberal trash political elite.

right?


2 posted on 04/01/2009 4:11:28 AM PDT by bill1952 (Power is an illusion created between those with power - and those without)
[ Post Reply | Private Reply | To 1 | View Replies]

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

Free Republic
Browse · Search
News/Activism
Topics · Post Article

FreeRepublic, LLC, PO BOX 9771, FRESNO, CA 93794
FreeRepublic.com is powered by software copyright 2000-2008 John Robinson